Sean Coughlin

Sean advises life sciences companies on building and defending patent positions that support their scientific, clinical and commercial goals. He helps teams navigate the intersection of intellectual property (IP) strategy, research and development priorities, and business decision-making.

Sean assists companies with translating complex biology and therapeutic approaches into durable global patent positions. His work includes US and international patent prosecution, freedom-to-operate analyses, portfolio management, and advising on IP issues in licensing and transactions. Sean has supported companies through investigational new drug preparation, clinical trial initiation and investor diligence, offering clear guidance connecting scientific detail with business needs.